Lutz Edler

15.5k total citations
245 papers, 8.6k citations indexed

About

Lutz Edler is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lutz Edler has authored 245 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Oncology, 67 papers in Molecular Biology and 55 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lutz Edler's work include Carcinogens and Genotoxicity Assessment (23 papers), Cancer Treatment and Pharmacology (19 papers) and Colorectal Cancer Treatments and Studies (18 papers). Lutz Edler is often cited by papers focused on Carcinogens and Genotoxicity Assessment (23 papers), Cancer Treatment and Pharmacology (19 papers) and Colorectal Cancer Treatments and Studies (18 papers). Lutz Edler collaborates with scholars based in Germany, United States and Switzerland. Lutz Edler's co-authors include Jürgen Debus, Stephanie E. Combs, Daniela Schulz–Ertner, Heinz Walter Thielmann, Iris Burkholder, Christoph Thilmann, Annette Kopp‐Schneider, Oliver Jäkel, Odilia Popanda and K. Mross and has published in prestigious journals such as The Lancet, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Lutz Edler

242 papers receiving 8.3k citations

Peers

Countries citing papers authored by Lutz Edler

Since Specialization

Citations

This map shows the geographic impact of Lutz Edler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lutz Edler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lutz Edler more than expected).

Fields of papers citing papers by Lutz Edler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lutz Edler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lutz Edler. The network helps show where Lutz Edler may publish in the future.

Co-authorship network of co-authors of Lutz Edler

This figure shows the co-authorship network connecting the top 25 collaborators of Lutz Edler. A scholar is included among the top collaborators of Lutz Edler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lutz Edler. Lutz Edler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Helical intensity-modulated radiotherapy of the pelvic lymph nodes with a simultaneous integrated boost to the prostate - first results of the PLATIN 1 trial 2015 ·BMC Cancer ·Gregor Habl, Sonja Katayama, Matthias Uhl, Kerstin A. Kessel, Lutz Edler, Jürgen Debus, Klaus Herfarth, Florian Sterzing	8
2	Angiopoietin-2 Levels Are Associated with Disease Progression in Metastatic Malignant Melanoma 2009 ·Clinical Cancer Research ·Iris Helfrich, Lutz Edler, Antje Sucker, Markus Thomas, Sven Christian, Dirk Schadendorf, Hellmut G. Augustin	152
3	Radiochemotherapy in Patients With Primary Glioblastoma Comparing Two Temozolomide Dose Regimens 2008 ·International Journal of Radiation OncologyBiologyPhysics ·Stephanie E. Combs, Johanna Wagner, Marc Bischof, Thomas Welzel, Lutz Edler, (unknown), Florian Wagner, A. Zabel-du Bois, Jürgen Debus, Daniela Schulz–Ertner	35
4	Polymorphisms in ABCG2, ABCC3 and CNT1 genes and their possible impact on chemotherapy outcome of lung cancer patients 2008 ·International Journal of Cancer ·(unknown), Heike Dally, (unknown), Lutz Edler, B Jäger, (unknown), B. Spiegelhalder, S Tuengerthal, Jürgen R. Fischer, P. Drings, Helmut Bartsch, Angela Risch	42
5	A Pilot Study of Docetaxel and Trofosfamide as Second-Line ‘Metronomic’ Chemotherapy in the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC) 2008 ·Onkologie ·(unknown), Christian R. Habermann, (unknown), (unknown), Gunter Schuch, Birte Andritzky, (unknown), Iris Burkholder, Lutz Edler, Dieter K. Hossfeld, Carsten Bokemeyer, Eckart Laack	22
6	Glucocorticoid-mediated inhibition of chemotherapy in ovarian carcinomas 2006 ·International Journal of Oncology ·Chengwen Zhang, Alexander Marmé, Till Wenger, Paul Gutwein, Lutz Edler, Werner Rittgen, Klaus‐Michael Debatin, Peter Altevogt, Jürgen Mattern, Ingrid Herr	39
7	Corticosteroids induce chemotherapy resistance in the majority of tumour cells from bone, brain, breast, cervix, melanoma and neuroblastoma 2006 ·International Journal of Oncology ·Chengwen Zhang, Benjamin M. Beckermann, Georgios Kallifatidis, Zheng Liu, Werner Rittgen, Lutz Edler, Peter Büchler, Klaus‐Michael Debatin, Markus W. Büchler, Helmut Friess, Ingrid Herr	73
8	Recent advances in quantitative methods in cancer and human health risk assessment 2005 ·John Wiley & Sons eBooks ·Lutz Edler, Christos P. Kitsos	15
9	Randomized Clinical Trial: Myths around Elementary Statistical Principles 2003 ·Oncology Research and Treatment ·Lutz Edler, Annette Kopp‐Schneider	0
10	New Clinical Trial Designs for Phase I Studies in Hematology and Oncology: Principles and Practice of the Continual Reassessment Model 1996 ·Oncology Research and Treatment ·A.-R. Hanauske, Lutz Edler	2
11	Phase II Clinical Trial of Lobaplatin (D-19466) in Pretreated Patients with Small-Cell Lung Cancer 1996 ·Oncology Research and Treatment ·H.H. Fiebig, H. Henß, (unknown), U. Gatzemeier, C. Manegold, Lutz Edler, Wolfgang E. Berdel	14
12	Adjuvant Chemotherapy with 5-Fluorouracil and Folinic Acid in Colorectal Cancer: Evaluation of Toxicity 1996 ·Oncology Research and Treatment ·G. Hartung, W. Queißer, (unknown), E. Hagmüller, Lutz Edler, (unknown), (unknown), Adrian M. Seifert, H. Weiß, H.J. Weh, M. Hoffknecht, (unknown), Dieter Fritze, Ruth L. Katz, M. Härle	4
13	Lobaplatin (D-19466) in Patients with Advanced Non-Small-Cell Lung Cancer: A Trial of the Association for Medical Oncology (AIO) Phase II Study Group 1996 ·Oncology Research and Treatment ·C. Manegold, P. Drings, U. Gatzemeier, Joachim von Pawel, H.H. Fiebig, W. Queißer, Lutz Edler	7
14	4′-lodo-4′-Deoxydoxorubicin (IDX) in Colorectal Cancer – A Multicenter Phase II Study 1995 ·Oncology Research and Treatment ·Richard Herrmann, K. Mross, Ulrich R. Kleeberg, E.D. Kreuser, R. Becher, Lutz Edler, W. Queißer, P. Liati, S. Kerpel‐Fronius	1
15	Relationship between dose and risk reduction: statistical evaluation of a combination experiment with three hepatocarcinogenic N-nitrosamines in rats. 1991 ·PubMed ·(unknown), D Schmähl, Lutz Edler	3
16	Phase II Study of Vinorelbine by Oral Route (in a Hard Gelatine Capsule) for Metastatic Breast Cancer Patients 1991 ·Oncology Research and Treatment ·W. Queißer, (unknown), (unknown), K. Bremer, R. Becher, (unknown), F.M. Delgado, Lutz Edler	6
17	Chemotherapie gastrointestinaler Tumoren 1990 ·Oncology Research and Treatment ·(unknown), H. O. Klein, (unknown), R. Herrmann, D Hossfeld, (unknown), P. Preusser, (unknown), (unknown), H.J. Weh, (unknown), Lutz Edler	1
18	Phase II Evaluation of Carboplatin in Advanced Esophageal Carcinoma 1990 ·Oncology Research and Treatment ·W. Queißer, P. Preusser, K. Mross, Dieter Fritze, (unknown), J. Beyer, W. Achterrath, Lutz Edler	9
19	Etoposide, Adriamycin, and Cisplatinum (EAP) Combination Chemotherapy for Advanced Gastric Cancer 1990 ·Oncology Research and Treatment ·U. Räth, Hans‐Henning Flechtner, (unknown), (unknown), C. Manegold, (unknown), (unknown), Lutz Edler, P. M. Schlag, W. Queißer	7
20	5-Fluorouracil, 4-Epidoxorubicin, and Mitomycin C (FEM) Combination Chemotherapy for Advanced Gastric Carcinoma. A Phase-II Trial by the “Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)” 1987 ·Oncology Research and Treatment ·Hans‐Henning Flechtner, W. Queißer, Manfred Heim, H. Henß, H. Arnold, Dieter Fritze, R. Herrmann, Holger Fritsch, (unknown), (unknown), (unknown), Lutz Edler	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact